Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Comment by Redbaron2211on Oct 18, 2019 11:26am
64 Views
Post# 30243910

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:The market

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:The marketSonny not that I dont agree that there was selling before the PP to take part but it was minimal in fact the month before the PP the avg volume was less then 200k with the highest day at around 500k.  Even after the news on July 3rd the volume was low until July 16th and then came in full swing after the PP was announced.  

A couple things that crossed my mind as possibilities.  

1. Pharma is accumulating stock to control the SP to favor a lower offer.

2.  Viacyte or other competitors are manipulating the SP and paying people like Biotech to keep the SP down making it harder to raise money ext/// 


   
Bullboard Posts